Jonas Ludvigsson
Appearances
- DateMay 8, 2023BACKGROUND: Aspirin has been known for its chemopreventive effect against various cancers. Evidence for the chemopreventive effect of the very long-term use of aspirin is still uncertain…
Presenter
Speakers
- DateMay 8, 2023BACKGROUND: Aspirin has been known for its chemopreventive effect against various cancers. Evidence for the chemopreventive effect of the very long-term use of aspirin is still uncertain…
Presenter
Speakers
- DateMay 8, 2023Early-onset colorectal cancer (CRC diagnosed before age 50) has risen worldwide, with an increasing number of survivors of reproductive age. We aimed to investigate the risk of adverse pregnancy and neonatal outcomes among early-onset CRC survivors…
Speakers
Presenter
- DateMay 9, 2023INTRODUCTION: A number of medications have been implicated as primary risk factors for microscopic colitis (MC) and guidelines recommend discontinuation of these medications as part of MC management…
Presenter
Massachusetts General Hospital - DateMay 19, 2024BACKGROUND: Microscopic colitis (MC) is an inflammatory condition of the colon, characterized by watery, non-bloody, diarrhoea…
Presenter
Speakers
- DateMay 21, 2024BACKGROUND: Several observational and randomized studies have found an association between aspirin use and lower risk of colorectal cancer (CRC) incidence and mortality…
Presenter
Speakers
Massachusetts General Hospital